Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideJNJJohnson & Johnson
FinDog View：Bullish
| Metric | JNJ | MRNA |
|---|
| Close | 267.28 | 145.62 |
| Market Cap | $644B | $58.1B |
| 1M | +1.87% | +125.91% |
| P/E (TTM) | 30.6 | — |
| Forward P/E | 20.7 | — |
| P/E 5-Yr Percentile | 90 | — |
| P/S | 6.6 | 25.8 |
| P/B | 7.6 | 8.5 |
| Dividend Yield | 3.12% | — |
| Latest Quarter Revenue | $25.3B | $145M |
| Revenue YoY | +6.6% | +2.1% |
| Gross Margin | 68.2% | 35.9% |
| Latest Quarter EPS | 2.27 | -1.97 |
| Avg Post-Earnings Move | ±0.6% | ±4.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.25% | — |
| 90-Day Net Insider Buying | −$67.8M | −$49.2M |
JNJ · Revenue, Last 8 Quarters ($B)
MRNA · Revenue, Last 8 Quarters ($B)
